RxDoctor Payments DataLook up a doctor →

Lacey Preston, PA

Physician Assistant · Augusta, GANPI 1912508532

Payments from drug & device makers

$15,216in general payments, 2019–2025

Across 750 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$803
  • Pfizer$802
  • Neurocrine Biosciences, Inc.$769
  • Argenx US, Inc.$765
  • AstraZeneca$744
  • plus $9K from 47 others

What the payments were for

  • Food & beverage$15,144100%
  • Education$730%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,216 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$9,134
Medicare patients
57
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RytaryCarbidopa/Levodopa63$117,563
QuliptaAtogepant55$77,928
GocovriAmantadine Hcl17$64,654
Lamictal XrLamotrigine13$63,864
Emgality PenGalcanezumab-Gnlm59$48,515
GlatopaGlatiramer Acetate15$47,051
Nurtec OdtRimegepant Sulfate12$25,712
UbrelvyUbrogepant16$16,616
Ajovy AutoinjectorFremanezumab-Vfrm20$15,911
BotoxOnabotulinumtoxina11$11,648
Carbidopa-LevodopaCarbidopa/Levodopa223$7,715
Memantine Hcl205$5,367
Duloxetine Hcl193$4,248
Depakote ErDivalproex Sodium13$4,016
Levetiracetam ErLevetiracetam40$3,943

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCRytary$104$117,56363 claims
AbbVieQulipta, Ubrelvy, Botox$2,270$106,19382 claims
MDD US Operations, LLCGocovri$191$64,65417 claims
PfizerNurtec Odt$802$25,71212 claims
Upsher-smith Laboratories LLCTopiramate$60$1,024100 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →